Doctor profile · Federal record
Dr. Elie Chalhoub, MD
Internal Medicine Physician (CMS: Hematology/Oncology) · Bemidji, MN
- NPI 1336451665
- Accepts Medicare
- MIPS 81.6 / 100 · 2023
- 17 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1705 Anne St Nw
Bemidji, MN 566016151
(218) 333-5000
Credentials & registration
- NPI registered
- July 2010 — 16 yrs on file
- Profile last updated
- April 4, 2022
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Kansas #7502
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336451665. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
49,228
Distinct HCPCS
10
Medicare allowed
$709,635
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 11,040 | 14 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,700 | 19 | $3 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 6,630 | 12 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 5,800 | 17 | $56 | |
J0897 |
Injection, denosumab, 1 mg | 4,200 | 34 | $24 | |
J0185 |
Injection, aprepitant, 1 mg | 3,380 | 17 | $2 | |
A9575 |
Injection, gadoterate meglumine, 0.1 ml | 2,431 | 18 | $0 | |
J1627 |
Injection, granisetron, extended-release, 0.1 mg | 1,700 | 15 | $6 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,620 | 14 | $44 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,218 | 66 | $0 |
In context: peer comparison
Among 6 peers in Bemidji Internal Medicine Physician, average services per provider: 670. This provider delivers 73× the peer median.Open Payments
Industry payments received
All-time total
$2,710
Transactions
90
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 11 | $208.52 | |
| Novartis Pharmaceuticals Corporation | 11 | $187.01 | |
| Pfizer INC. | 11 | $182.99 | |
| E.R. Squibb & Sons, L.L.C. | 13 | $146.28 | |
| Daiichi Sankyo INC. | 6 | $132.23 | |
| Eisai INC. | 6 | $108.89 | |
| Janssen Biotech, INC. | 4 | $98.18 | |
| Takeda Pharmaceuticals U.S.A., INC. | 3 | $92.23 | |
| Servier Pharmaceuticals LLC | 4 | $82.79 | |
| Celgene Corporation | 4 | $80.27 | |
| Exelixis INC. | 3 | $76.32 | |
| Gilead Sciences, INC. | 4 | $75.98 | |
| Genzyme Corporation | 4 | $74.31 | |
| Alexion Pharmaceuticals, INC. | 3 | $69.85 | |
| Deciphera Pharmaceuticals INC. | 3 | $63.86 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
418
Patients
137
Total drug cost
$534,357
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dexamethasone | Generic | 45 | 16 | $273 |
| Acyclovir | Generic | 43 | 0 | $700 |
| Prochlorperazine Maleate | Generic | 35 | 30 | $713 |
| Prednisone | Generic | 34 | 15 | $172 |
| Ondansetron Hcl | Generic | 31 | 21 | $1,070 |
| Abiraterone Acetate | Generic | 30 | 0 | $84,589 |
| Anastrozole | Generic | 28 | 17 | $901 |
| Olanzapine | Generic | 25 | 0 | $90 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 25 | 0 | $62 |
| Hydroxyurea | Generic | 24 | 14 | $921 |
Hospital affiliations
Frequently asked questions
What is Dr. Elie Chalhoub's medical specialty?
Dr. Elie Chalhoub practices Internal Medicine Physician in Bemidji, MN.
Where does Dr. Elie Chalhoub practice?
Dr. Elie Chalhoub practices at 1705 Anne St Nw, Bemidji, MN 566016151. Office phone: 2183335000.
What is Dr. Elie Chalhoub's NPI?
Dr. Elie Chalhoub's National Provider Identifier (NPI) is 1336451665, issued by NPPES.
Does Dr. Elie Chalhoub accept Medicare assignment?
Yes. Dr. Elie Chalhoub accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Elie Chalhoub commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138). Source: CMS Medicare Physician & Other Practitioners file.